Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-05-17
2011-05-17
Kosack, Joseph (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S171000
Reexamination Certificate
active
07943613
ABSTRACT:
Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds are activators of PPARδ and should be useful for treating conditions mediated by the same.
REFERENCES:
patent: 4148915 (1979-04-01), Thuillier et al.
patent: 4920132 (1990-04-01), Huang et al.
patent: 5324743 (1994-06-01), Dillard et al.
patent: 5773469 (1998-06-01), Kanojia et al.
patent: 5919793 (1999-07-01), Brown et al.
patent: 6448293 (2002-09-01), Andrews et al.
patent: 6525094 (2003-02-01), Zhang et al.
patent: 6555577 (2003-04-01), Mogensen et al.
patent: 6569901 (2003-05-01), Mogensen et al.
patent: 6630504 (2003-10-01), Andrews et al.
patent: 6867218 (2005-03-01), Mogensen et al.
patent: 6869967 (2005-03-01), Jeppesen et al.
patent: 6869975 (2005-03-01), Abe et al.
patent: 6875780 (2005-04-01), Auerbach et al.
patent: 6972294 (2005-12-01), Murray et al.
patent: 7067530 (2006-06-01), Jeppesen et al.
patent: 7091245 (2006-08-01), Jeppesen et al.
patent: 7129268 (2006-10-01), Jeppesen et al.
patent: 7202213 (2007-04-01), Mogensen et al.
patent: 7220877 (2007-05-01), Sauerberg et al.
patent: 7709528 (2010-05-01), Jeppesen et al.
patent: 2004/0024034 (2004-02-01), Brooks et al.
patent: 2005/0080115 (2005-04-01), Jeppesen et al.
patent: 2008/0114036 (2008-05-01), Havranek et al.
patent: 2009/0012171 (2009-01-01), Polivka
patent: 2009/0048257 (2009-02-01), Sauerberg
patent: 2009/0192162 (2009-07-01), Ebdrup
patent: 2010/0197950 (2010-08-01), Rasmussen et al.
patent: 2010/0210653 (2010-08-01), Havranek et al.
patent: 2003/171275 (2003-06-01), None
patent: 97/27847 (1997-08-01), None
patent: 97/27857 (1997-08-01), None
patent: 97/28115 (1997-08-01), None
patent: 97/28137 (1997-08-01), None
patent: 97/28149 (1997-08-01), None
patent: 97/43241 (1997-11-01), None
patent: 97/48674 (1997-12-01), None
patent: 98/27974 (1998-07-01), None
patent: 99/04815 (1999-02-01), None
patent: WO 99/20275 (1999-04-01), None
patent: 00/63153 (2000-10-01), None
patent: 01/00603 (2001-01-01), None
patent: 01/25181 (2001-04-01), None
patent: WO 01/25226 (2001-04-01), None
patent: WO 01/34137 (2001-05-01), None
patent: WO 01/34200 (2001-05-01), None
patent: 01/55085 (2001-08-01), None
patent: 01/55086 (2001-08-01), None
patent: WO 01/60807 (2001-08-01), None
patent: WO 01/66098 (2001-09-01), None
patent: 01/79150 (2001-10-01), None
patent: 01/79197 (2001-10-01), None
patent: 02/14291 (2002-02-01), None
patent: WO 02/28434 (2002-04-01), None
patent: 02/46154 (2002-06-01), None
patent: WO 02/50048 (2002-06-01), None
patent: WO 02/053547 (2002-07-01), None
patent: 02/059098 (2002-08-01), None
patent: WO 02/062774 (2002-08-01), None
patent: WO 02/070011 (2002-09-01), None
patent: 02/076957 (2002-10-01), None
patent: 02/079162 (2002-10-01), None
patent: 02/080899 (2002-10-01), None
patent: 02/098840 (2002-12-01), None
patent: 02/100812 (2002-12-01), None
patent: WO 03/002081 (2003-01-01), None
patent: 03/011814 (2003-02-01), None
patent: 03/016265 (2003-02-01), None
patent: 03/016291 (2003-02-01), None
patent: WO 03/011807 (2003-02-01), None
patent: WO 03/024395 (2003-03-01), None
patent: 03/033453 (2003-04-01), None
patent: 03/033493 (2003-04-01), None
patent: 03/035603 (2003-05-01), None
patent: 03/072100 (2003-09-01), None
patent: 03/074050 (2003-09-01), None
patent: WO 03/074051 (2003-09-01), None
patent: WO 03/074052 (2003-09-01), None
patent: WO 03/074495 (2003-09-01), None
patent: 03/084916 (2003-10-01), None
patent: 03/097607 (2003-11-01), None
patent: WO 2004/000315 (2003-12-01), None
patent: WO 2004/000762 (2003-12-01), None
patent: 2004/005253 (2004-01-01), None
patent: WO 2004/007439 (2004-01-01), None
patent: 2004/022533 (2004-03-01), None
patent: WO 2004/037775 (2004-05-01), None
patent: WO 2004/037776 (2004-05-01), None
patent: WO 2004/060871 (2004-07-01), None
patent: WO 2004/063165 (2004-07-01), None
patent: WO 2004/063166 (2004-07-01), None
patent: WO 2004/073606 (2004-09-01), None
patent: WO 2004/080943 (2004-09-01), None
patent: WO 2004/080947 (2004-09-01), None
patent: WO 2004/092117 (2004-10-01), None
patent: WO 2004/093879 (2004-11-01), None
patent: WO 2004/099170 (2004-11-01), None
patent: WO 2005/054176 (2005-06-01), None
patent: WO 2005/097098 (2005-10-01), None
patent: WO 2005/097762 (2005-10-01), None
patent: WO 2005/097763 (2005-10-01), None
patent: 2005/105725 (2005-11-01), None
patent: 2005/105736 (2005-11-01), None
patent: WO 2005/105735 (2005-11-01), None
patent: WO 2005105735 (2005-11-01), None
patent: 2007/003581 (2007-01-01), None
patent: 2007/101864 (2007-09-01), None
patent: 2007/141295 (2007-12-01), None
Landreth et al. Neurobiology of Aging, 2001, 22, 937-944.
Peters et al. Biochimica et Biophysica Acta 2009, 1796, 230-241.
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
Epple et al. Bioorganic & Medicinal Chemistry Letters 2006, 16, 4376-4380.
Gross et al. Best Practice & Research Clinical Endocrinology & Metabolism 2007, 21, 687-710.
Colagiuri et al. American Journal of Public Health, Sep. 2006, vol. 96, No. 9, pp. 1562-1569.
Park Diabetes Research and Clinical Practice 66S (2004), S33-S35.
Curtis et al. The Journal of the American Board of Family Practice, vol. 18, pp. 37-43, (2005).
Hussain et al. Diabetes Research and Clinical Practice 2007, 76, 317-326.
Giron, D. J. Therm. Anal. Cal. 2001, 64, pp. 37-60.
Giron, D. J. Therm. Anal. Cal. 2002, 68, pp. 335-357.
B. Rodriquez-Spong et al. Advanced Drug Delivery Reviews, 2004, 56, pp. 241-274.
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry, pp. 217-218 (in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227).
Berger, Joel et al., “Novel Peroxisome Proliferator-activated Receptor (PPAR) gamma and PPAR delta Ligands Produce Distinct Biological Effect” Journal of Biological Chemistry, vol. 274, No. 10, Issue of March 5, pp. 6718-6725, 1999.
Leibowitz, Mark D. et al., “Activation of PPAR delta alters lipidmetabolism in db/db mice” FEBS Letters 473 (2000) pp. 333-336.
Muoio, Deborah M. “Fatty Acid Homestasis and Induction of Lipid Regulatory Genes in Skeletal Muscles of Peroxisome Proliferator-activated Receptor (PPAR) Knock-out Mice” Journal of Biological Chemistry, vol. 277, No. 29, Issue of July 19, pp. 26089-26097, 2002.
Oliver, William R. Jr. et al., “A Selective peroxisome proliferator-activated receptor delta agonist promotes reverse cheolesterol transport” Proceedings of the National Academy of Sciences, vol. 98, No. 9 pp. 5306-5311, Apr. 24, 2001.
PCT International Search Report for Application No. PCT/EP2006/070096 dated Jul. 26, 2007.
Vippagunta, S.R. et al., Adv. Drug Delivery Rev. 48 (2001) 3-26.
Caira, M.R., Topics in Current Chem. 198 (1998) 163-208.
Guillory, J.K., “Generation of Polymorphs, Hydrates, Solvates, and Amorphous Solids” in Polymorphism in Pharmaceutical Solids (Brittain, H.G., ed., 1999) 183-226.
Byrn, S.R. et al., Solid-State Chemistry of Drugs, 2nd edition (1999) 233-248 (Chapter 11).
U.S. Appl. No. 11/917,811, Notice of Allowance, dated Feb. 18, 2011.
U.S. Appl. No. 12/282,244, Notice of Allowance, dated Feb. 22, 2011.
M. Havranek et al., “E/Z Isomerization of 3,3-disubstituted allylic thioethers” Tetrahedron Lett., vol. 48, pp. 6970-6973 (2007).
P. Sauerberg et al., “Identification and Synthesis of a Novel Selective Partial PPAR-delta Agonist with Full Efficacy on Lipid Metabolism In Vitro and In Vivo” J. Med. Chem., vol. 50, pp. 1495-1503 (2007).
M. Tiikkainen et al., “Effects of Rosiglitazone and Metformin on Liver Fat Content . . . ” Diabetes, vol. 53, pp. 2169-2176 (2004).
T. Wilson et al., “The PPARs: From Orphan Receptors to Drug Discovery” J. Med. Chem., vol. 43(4), pp. 527-550 (2000).
S. Kersten et al., “Roles of PPARs in health and disease” Nature, vol. 405, pp. 421-424 (2000).
F. Kaplan et al
Havranek Miroslav
Mogensen John Patrick
Pettersson Ingrid
Pihera Pavel
Polivka Zdenek
Coughlin Matthew P
Dailey Robert S.
High Point Pharmaceuticals, LLC
Kosack Joseph
LandOfFree
Compounds, their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, their preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2679173